95 filings
Page 2 of 5
6-K
tz7ivsjmfhuaomye77kd
16 May 23
ERYTECH Provides Update on the Announced Combination with PHERECYDES
10:14am
6-K
s6gb bbz8mam8trj0khb
10 May 23
ERYTECH Provides Business and Financial Update for the First Quarter of 2023
8:55am
6-K
5su9o49kojda4yi ta
18 Apr 23
ERYTECH Announces Approval to Transfer its Listing to the Nasdaq Capital Market
8:20am
6-K
m8wui c90f
23 Mar 23
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2022
9:37am
6-K
odmiskhdlup1j
16 Feb 23
This press release does not constitute an offer to purchase any securities
4:25pm
6-K
ggtm5
22 Nov 22
ERYTECH Provides Business and Financial Update for the Third Quarter of 2022
11:08am
6-K
kuniq2ha
14 Oct 22
ERYTECH Announces Receipt of Nasdaq Notice
6:11am
6-K/A
0nqf slwo
12 Sep 22
I.Certification of the Person Responsible for the Half-year Financial Report
4:33pm
6-K
36m8 lrl7ax27
12 Sep 22
I.Certification of the Person Responsible for the Half-year Financial Report
12:04pm
6-K
tgrx74u9mjefzk4h9xnf
25 Aug 22
ERYTECH Provides Regulatory Update
10:13am
6-K
24wh7772seplit
28 Jun 22
Current report (foreign)
9:01am
6-K
g52uay0mi9wkn7whix
25 May 22
Current report (foreign)
8:11am
6-K
p5qrzy9oi0kfg8 0wxx
13 May 22
ERYTECH Provides Business and Financial Update for the First Quarter of 2022
11:37am
6-K
qm8dt8fe5
2 May 22
ERYTECH Announces Filing of 2021 Universal Registration Document and 2021 Annual Report on Form 20-F, as well as its 2022 financial calendar
9:47am
6-K
3166 hvk4kxl
28 Apr 22
Asset Purchase Agreement
8:30am
6-K
0gjmag351l g41pb
25 Apr 22
Current report (foreign)
4:31pm
6-K
4odez4vzu4p5bxo
15 Mar 22
ERYTECH Provides Business and Financial Update for the Fourth Quarter and Full Year 2021
9:19am
6-K
u82f4iau7bxnci
10 Feb 22
ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases
8:19am
6-K
ytstwga3fd
27 Jan 22
ERYTECH Announces Presentation of
1:20pm
6-K
xq4qr fn3i3b
16 Dec 21
Erytech Announces Presentation of Results of Expanded Access Program In All at 2021 Ash Annual Meeting and Acceptance of Two Abstracts at Asco Gi
5:23pm